163 related articles for article (PubMed ID: 33611055)
1. Doxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection.
Santos MP; Gonçalves-Santos E; Gonçalves RV; Santos EC; Campos CC; Bastos DSS; Marques MJ; Souza RLM; Novaes RD
Int Immunopharmacol; 2021 May; 94():107462. PubMed ID: 33611055
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline hyclate: A schistosomicidal agent in vitro with immunomodulatory potential on granulomatous inflammation in vivo.
Dias MV; Castro AP; Campos CC; Souza-Silva TG; Gonçalves RV; Souza RLM; Marques MJ; Novaes RD
Int Immunopharmacol; 2019 May; 70():324-337. PubMed ID: 30852288
[TBL] [Abstract][Full Text] [Related]
3. Doxycycline hyclate stimulates inducible nitric oxide synthase and arginase imbalance, potentiating inflammatory and oxidative lung damage in schistosomiasis.
Souza MA; Gonçalves-Santos E; Gonçalves RV; Santos EC; Campos CC; Marques MJ; Souza RLM; Novaes RD
Biomed J; 2022 Dec; 45(6):857-869. PubMed ID: 34971826
[TBL] [Abstract][Full Text] [Related]
4. Dietary glycemic and energy load differentially modulates Schistosoma mansoni-induced granulomatous inflammation and response to antiparasitic chemotherapy.
Reis LFCD; Cerdeira CD; Silva LCC; Ramos ABSB; Silva JEC; Castro AP; Ventura RR; Souza RLM; Marques MJ; Novaes RD
Acta Trop; 2024 Apr; 252():107141. PubMed ID: 38342286
[TBL] [Abstract][Full Text] [Related]
5. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
6. Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.
Khayeka-Wandabwa C; Zhou G; Magak NG; Choge JK; Kemei WK; Makwali JA; Karani LW; Kisavi MP; Ndulu JV; Anjili CO
Exp Parasitol; 2019 Sep; 204():107728. PubMed ID: 31348915
[TBL] [Abstract][Full Text] [Related]
7. Pathological and immunological evaluation of different regimens of praziquantel treatment in a mouse model of Schistosoma mansoni infection.
Membe Femoe U; Boukeng Jatsa H; Greigert V; Brunet J; Cannet C; Kenfack MC; Gipwe Feussom N; Kadji Fassi JB; Tienga Nkondo E; Abou-Bacar A; Pfaff AW; Dimo T; Kamtchouing P; Tchuem Tchuenté LA
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010382. PubMed ID: 35446855
[TBL] [Abstract][Full Text] [Related]
8. Dandelion (Taraxacum officinale) Improves the Therapeutic Efficiency of Praziquantel in Experimental Schistosomiasis.
Atwa MTM; Abd-Elrazek AM; Salem NIS
Acta Parasitol; 2022 Jun; 67(2):773-783. PubMed ID: 35067863
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.
El-Lakkany NM; Hammam OA; El-Maadawy WH; Badawy AA; Ain-Shoka AA; Ebeid FA
Parasit Vectors; 2012 Jan; 5():9. PubMed ID: 22236605
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
[TBL] [Abstract][Full Text] [Related]
12. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
[TBL] [Abstract][Full Text] [Related]
14. Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni: A novel insight.
Abd El-Aal NF; Hamza RS; Harb O
Exp Parasitol; 2017 Dec; 183():23-32. PubMed ID: 29037782
[TBL] [Abstract][Full Text] [Related]
15. Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice.
Elsakkar MG; Eissa MM; Hewedy WA; Nassra RM; Elatrebi SF
Life Sci; 2016 Oct; 162():95-101. PubMed ID: 27528511
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
Sabra AA; Salem MB; William S; Hammam OA; El-Lakkany NM
Exp Parasitol; 2022 Aug; 239():108293. PubMed ID: 35667394
[TBL] [Abstract][Full Text] [Related]
17. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
18. Schistosomicidal and hepatoprotective activity of gamma-aminobutyric acid (GABA) alone or combined with praziquantel against Schistosoma mansoni infection in murine model.
Fahmy AM; William S; Hegab A; Tm D
Exp Parasitol; 2022 Jul; 238():108260. PubMed ID: 35447136
[TBL] [Abstract][Full Text] [Related]
19. An adjuvant effect of Metformin as an anti-fibrotic agent when administered with the anti-schistosomal Praziquantel in Schistosoma mansoni infected mice.
Salama WM; El-Naggar SA; Harras SF; El-Said KS
Trop Biomed; 2021 Jun; 38(2):205-213. PubMed ID: 34172712
[TBL] [Abstract][Full Text] [Related]
20. Immunohistopathological changes in murine Schistosomiasis mansoni under the influence of N-acetyl-L-cysteine.
de Lima Aires A; de Azevedo Albuquerque MC; Silva RA; Schirato GV; de Pontes Filho NT; de Araújo SB; Souza VM; Costa VM; Malagueño E
Parasitol Res; 2012 Oct; 111(4):1569-78. PubMed ID: 22773008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
